Trial Profile
A Pilot Study to Evaluate Whether the Cardiovascular Side Effects of Bevacizumab caused by Autonomic Nervous System (ANS) Toxicity in Patients with Colon Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- 18 Dec 2015 New trial record